4.7 Review

DNA polymerase beta (pol β) inhibitors: A comprehensive overview

Journal

DRUG DISCOVERY TODAY
Volume 17, Issue 15-16, Pages 913-920

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2012.04.008

Keywords

-

Funding

  1. NSERC
  2. Alberta Cancer Foundation, Alberta Cancer Research Institute, Canadian Breast Cancer Foundation, Alberta Advanced Education and Technology
  3. Allard Foundation

Ask authors/readers for more resources

Base excision repair (BER) is the fundamental pathway responsible for the elimination of damaged DNA bases and repair of DNA single-strand breaks generated spontaneously or produced by DNA-damaging agents. Among the essential enzymes that are required to achieve the BER reaction is DNA polymerase beta (pot beta), which has been regarded as a potential therapeutic target. More than 60 pol beta-inhibitors have been identified so far; however, most of them are either not potent or not specific enough to become a drug. In this article we compile an essential knowledge base regarding the structures, the modes of inhibition and the activities of these pharmacologically interesting molecules.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available